预测根治性前列腺切除术后早期生化复发的新版Walz列线图
模型基于术前PSA、病理Gleason评分、肿瘤分期、淋巴结及手术切缘状态,外部验证准确率达81%,校准与决策曲线分析优于Walz列线图、MSKCC列线图和CAPRA-S评分。
要点
- 新版eBCR列线图外部验证准确率达81%,校准和决策曲线分析优于现有工具。
- 模型仅依赖术前PSA、病理Gleason评分、肿瘤分期、淋巴结及手术切缘状态。
- 该工具可能帮助避免对部分患者立即行辅助放疗,且漏诊eBCR比例低。
核心结论
- 更新版eBCR列线图易于应用、准确度高,可能使大部分患者避免立即辅助放疗,且伴随的漏诊eBCR病例较少。
- 该工具与同类工具相比具有优势。
研究设计与样本
- 使用受试者工作特征曲线下面积(AUC)、Heagerty C指数和决策曲线分析(DCA)量化模型准确性,并与Walz列线图、在线MSKCC列线图和CAPRA-S评分比较。
主要发现
- eBCR列线图依赖术后12和24个月的独立BCR预测因子:术前PSA、病理Gleason评分、肿瘤分期、淋巴结和手术切缘状态。
- 外部验证中两个时间点的准确率均为81%。
- 与Walz列线图、MSKCC列线图和CAPRA-S评分相比,当前列线图校准最佳、DCA结果最优,在截断值分析中避免辅助放疗的比例最高。
关键数值与推荐
- 外部验证准确率:81%(术后12和24个月)。
- 模型预测因子:术前PSA、病理Gleason评分、肿瘤分期、淋巴结状态、手术切缘状态。
临床怎么用
- 用于根治性前列腺切除术后预测12和24个月早期生化复发风险。
- 可辅助识别可能避免立即辅助放疗的低风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early biochemical recurrence (eBCR) after radical prostatectomy (RP) heralds poor oncological outcomes and may be prevented with adjuvant radiation (aRT). METHODS: We developed a contemporary eBCR nomogram in 13 797 RP patients from Hamburg (2005-2016) and externally validated it in 5952 RP patients from Vienna. Receiver operating characteristics-derived area under the curve (AUC), Heagerty's C-index, and decision curve analysis (DCA) were used to quantify model accuracy and to compare the current tool with the Walz nomogram, the online Memorial Sloan Kettering Cancer Center (MSKCC) nomogram and the post-surgical Cancer of the Prostate Risk Assesment (CAPRA-S). RESULTS: The eBCR nomogram relies on independent BCR predictors at 12 and 24 months after RP: preoperative PSA, pathological Gleason Score, tumor stage, lymph node, and surgical margin status. It achieved 81% accuracy at both time points in external validation. Additionally, the current nomogram yielded best calibration, optimal DCA results, and highest rates of avoided aRT in cutoff analyses, compared to the Walz nomogram, the MSKCC nomogram, and the CAPRA-S score. CONCLUSIONS: The updated eBCR nomogram is easily applicable, highly accurate, and may allow avoiding immediate aRT in a large proportion of patients with few concomitant missed eBCR instances. It compares favorably to similar tools.
引用
- Pompe RS, Bandini M, Preisser F, et al. Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram. Prostate Cancer Prostatic Dis. 2018. PMID: 29487397. doi:10.1038/s41391-018-0033-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。